MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
INTS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Intensity Therapeutics (INTS) Ownership - Who owns Intensity Therapeutics?

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
16
Web
https://www.intensitytherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.6M
P/E Ratio
N/A
Total Cash
10.25M
Projected Growth
N/A
Total Debt
102K
Revenue
N/A
Risk (Beta)
3.08
Dividend Yield
N/A
Total Cash/Share
3.79
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
INTS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for INTS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
16
Web
https://www.intensitytherapeutics.com